February 17, 2022
Healios, a Tokyo based biotech, is set to hold preapplication consultations with the Pharmaceuticals and Medical Devices Agency (PMDA) as early as the second half of March for its off-the-shelf somatic stem cell product MultiStem (HLCM051) for the treatment of...read more